Last update 08 May 2025
Zhaoqing Xinghu Pharmaceutical Co. Ltd.

Zhaoqing Xinghu Pharmaceutical Co. Ltd.

Private Company|1991|Guangdong Sheng, China|
mall.jd.com

Overview

Tags

Nervous System Diseases
Cardiovascular Diseases
Herbal medicine

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
no Data
No Data
Disease DomainCount
Nervous System Diseases1
Top 5 Drug TypeCount
Herbal medicine1

Related

2
Drugs associated with Zhaoqing Xinghu Pharmaceutical Co. Ltd.
Memantine hydrochloride
Target
NMDA receptor
Mechanism
NMDA receptor antagonists
Active Org.
Accord Healthcare SLU [+11]
Originator Org.
Merz Pharma GmbH & Co. KGaAMerz Pharma GmbH & Co. KGaA
Active Indication
Alzheimer Disease [+2]
Inactive Indication
Agitation [+18]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
Germany
First Approval Date11 Aug 2000
Xinanling Capsule
Target-
Mechanism-
Active Org.
Zhaoqing Xinghu Pharmaceutical Co. Ltd.Zhaoqing Xinghu Pharmaceutical Co. Ltd. [+1]
Originator Org.-
Active Indication
Angina Pectoris [+1]
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
4
Clinical Trials associated with Zhaoqing Xinghu Pharmaceutical Co. Ltd.
CTR20131852
/ Not yet recruitingPhase 1
心安灵胶囊在中国健康人体中的单中心、随机、双盲的单次、多次人体耐受性试验
[Translation] A single-center, randomized, double-blind, single-dose and multiple-dose human tolerance study of Xin'anling capsule in healthy Chinese subjects
CTR20140709
/ CompletedPhase 1
盐酸美金刚片(10mg)单次给药人体药代动力学研究
[Translation] Study on the pharmacokinetics of single-dose memantine hydrochloride tablets (10 mg) in humans
CTR20140717
/ SuspendedPhase 2
盐酸美金刚片治疗老年性痴呆患者的多中心、随机、双盲双模拟、阳性平行对照疗效和安全性临床研究
[Translation] A multicenter, randomized, double-blind, double-dummy, positive parallel controlled clinical study on the efficacy and safety of memantine hydrochloride tablets in the treatment of patients with senile dementia
100 Clinical Results associated with Zhaoqing Xinghu Pharmaceutical Co. Ltd.
Login to view more data
0 Patents (Medical) associated with Zhaoqing Xinghu Pharmaceutical Co. Ltd.
Login to view more data
100 Deals associated with Zhaoqing Xinghu Pharmaceutical Co. Ltd.
Login to view more data
100 Translational Medicine associated with Zhaoqing Xinghu Pharmaceutical Co. Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 24 Aug 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1 Clinical
1
1
Other
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Xinanling Capsule
Angina Pectoris
More
Phase 1
Memantine hydrochloride
 ( NMDA receptor )		Alzheimer Disease
More
Suspended
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free